Simvastatin improves flow-mediated dilation but reduces adiponectin levels and insulin sensitivity in hypercholesterolemic patients - Test2 - elhamkhani - TriplyDB

Simvastatin improves flow-mediated dilation but reduces adiponectin levels and insulin sensitivity in hypercholesterolemic patients

Simvastatin improves flow-mediated dilation but reduces adiponectin levels and insulin sensitivity in hypercholesterolemic patients

http://www.wikidata.org/entity/Q34177113

about

Role of lipotoxicity in endothelial dysfunction Adipocytokines and insulin resistance: the possible role of lipocalin-2, retinol binding protein-4, and adiponectin.Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients.Pharmacological effects of lipid-lowering drugs on circulating adipokines.Statin myalgia is not associated with reduced muscle strength, mass or protein turnover in older male volunteers, but is allied with a slowing of time to peak power output, insulin resistance and differential muscle mRNA expression.Edible bird's nest attenuates procoagulation effects of high-fat diet in rats.Effects of Ezetimibe/Simvastatin and Rosuvastatin on Oxidative Stress in Diabetic Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.Statins can delay insulin use and reduce diabetes-related diseases in Asian patients with type 2 diabetes Rosuvastatin Worsens Insulin Resistance in HIV-Infected Adults on Antiretroviral Therapy.High fat diet-induced inflammation and oxidative stress are attenuated by N-acetylneuraminic acid in rats.Effects of simvastatin on serum adiponectin: a meta-analysis of randomized controlled trials N-Acetylneuraminic acid attenuates hypercoagulation on high fat diet-induced hyperlipidemic rats.Differential metabolic actions of specific statins: clinical and therapeutic considerations The vascular endothelium in diabetes--a therapeutic target?Rosuvastatin does not affect fasting glucose, insulin resistance, or adiponectin in patients with mild to moderate hypertension Combination pravastatin and valsartan treatment has additive beneficial effects to simultaneously improve both metabolic and cardiovascular phenotypes beyond that of monotherapy with either drug in patients with primary hypercholesterolemia.Differential metabolic effects of pravastatin and simvastatin in hypercholesterolemic patients.Statins and risk of new-onset diabetes mellitus: is there a rationale for individualized statin therapy?Do statins cause diabetes?Adiponectin and lipoprotein metabolism.Pathogenesis and management of the diabetogenic effect of statins: a role for adiponectin and coenzyme Q10?Safety considerations with fenofibrate/simvastatin combination.The safety of ezetimibe and simvastatin combination for the treatment of hypercholesterolemia.Combining Potent Statin Therapy with Other Drugs to Optimize Simultaneous Cardiovascular and Metabolic Benefits while Minimizing Adverse Events.Simvastatin inhibits glucose metabolism and legumain activity in human myotubes.Comparison of the effects of simvastatin vs. rosuvastatin vs. simvastatin/ezetimibe on parameters of insulin resistance.Lipid-lowering agents and new onset diabetes mellitus.Effects of high-dose simvastatin therapy on glucose metabolism and ectopic lipid deposition in nonobese type 2 diabetic patients.Effect of simvastatin vs. rosuvastatin on adiponectin and haemoglobin A1c levels in patients with non-ischaemic chronic heart failure.Serum resistin and adiponectin levels in women with polycystic ovary syndrome.

P2860

Q27000731-F9E5B2ED-D06D-46EC-A1ED-3B81CFBFC807 Q33610718-E7CAC8B3-66ED-43D0-9F00-3B90C6F331FC Q34467145-CE51D905-DB72-4C41-860E-583856859FFB Q34877922-F46D6A8F-BC9D-4B26-A39E-7C68A273816C Q35174188-E270B422-DCDC-45F8-934F-5D21D2744C74 Q35914770-98E798D2-5161-481E-AB39-0C9F32158C06 Q35935501-E57524F0-71E1-4EBE-9D6B-BB85B3F4117C Q36153656-595B2D01-B619-4907-AFA6-9FE31DF31217 Q36187629-07F4B234-80C5-4069-B2ED-7A172E48185C Q36203090-6868DCBF-87E4-480A-A5ED-B1A7D4AA06B3 Q36306780-CC03D562-8DB8-484A-9416-20852EC1C68A Q36351051-5F5C8655-EBD1-4268-9BD3-BC3FF8EB53B4 Q36406951-DD9D835F-885A-4E3B-BB2A-FB1E326F119D Q36673550-0499C06E-C40D-4476-9218-C11BF4608F97 Q36837587-A3392E16-D533-4624-BA5F-A35EB29DC06C Q37193394-6923BEE2-C344-4C9C-98B0-4A67B92EF1AD Q37362218-EC03BAEB-F1F7-4150-9019-FD31C85ACDB9 Q37653189-B4CE3E78-E852-43E4-80FC-7F37BCAF2A49 Q38086101-3AD5CD2E-C4E9-4961-945F-B425A2B1BB8C Q38129920-D98EF355-D40C-41A9-BB36-4C776DFBCBC3 Q38268344-D0878E20-1806-4773-987E-D0C7F6962721 Q38541832-7B371B1C-7103-4BE4-8B5C-3F0EB16F3A7E Q38742876-BAFD38F0-B682-4569-B4CD-86565EA72F36 Q41190859-604978E2-6D0D-4D39-9813-E18DED0CCC45 Q41860525-2085C704-E959-4DF7-AE70-5CC7421275BD Q42495891-E3B368C2-C956-4D08-A94E-CF07A33F5F70 Q43058605-383C9F36-5A64-4A99-A561-A81983AB345F Q43196308-650E4B7D-F55B-4336-930B-A53D60D89C60 Q43248481-4BE790FA-CB8C-4692-B078-3F2EE6ABF606 Q46029238-2BBE5B55-C4EF-4F21-83CC-2655C51C3F79

P2860

Simvastatin improves flow-mediated dilation but reduces adiponectin levels and insulin sensitivity in hypercholesterolemic patients

http://www.wikidata.org/entity/Q34177113

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Simvastatin improves flow-medi ...... hypercholesterolemic patients

@ast

Simvastatin improves flow-medi ...... hypercholesterolemic patients

@en

Simvastatin improves flow-medi ...... hypercholesterolemic patients

@nl

type

label

Simvastatin improves flow-medi ...... hypercholesterolemic patients

@ast

Simvastatin improves flow-medi ...... hypercholesterolemic patients

@en

Simvastatin improves flow-medi ...... hypercholesterolemic patients

@nl

prefLabel

Simvastatin improves flow-medi ...... hypercholesterolemic patients

@ast

Simvastatin improves flow-medi ...... hypercholesterolemic patients

@en

Simvastatin improves flow-medi ...... hypercholesterolemic patients

@nl

P1433

Q34177113-C358B635-E509-47F8-BBA0-8A6E358D84F6

P1476

Q34177113-450A83BD-D86E-4451-94E6-E9CC0A05262E

P2093

Q34177113-2F578CEB-CC45-4394-979E-7A06EE1FFA10

Q34177113-401F46E4-43E1-4880-8974-98D350F4F84D

Q34177113-7A1C80AE-A1E9-4788-BA0C-811BECE23BB5

Q34177113-982FE096-3A44-4EA6-B352-E35EE28FB611

Q34177113-A94AEB78-98C2-4721-B5E3-BE517D7DF2EA

Q34177113-E711B7E3-BAB6-4D45-A7C4-E35073AFFA46

Q34177113-FEA70CCF-F6C7-476C-998E-CDF64869D7BD

P2860

Q34177113-0563D25C-19E7-4D42-B894-FD8E7341FDE2

Q34177113-113FE950-6153-49C5-B35B-54A055EA102A

Q34177113-1CA6DB5E-463F-46AF-B498-F8B5EC772EF0

Q34177113-2152A2D6-F469-404C-9701-54600C37D8C3

Q34177113-267E78CA-9B52-4B27-9B0E-2F420E14EF92

Q34177113-34B216EF-D215-4149-B052-504FDAC84BAC

Q34177113-75A6F5FB-0CDD-4CEA-A097-EAAC12C23837

Q34177113-769EE22E-3755-44C0-A8D2-0A4C5776012C

Q34177113-7A880E3D-D2F0-49D3-9CD8-CD3A4EC68D8A

Q34177113-9717BE7C-8B42-4254-815C-DCA5361E07A9

P304

Q34177113-92971CCA-65EF-423D-80DA-91C399D3103A

P31

Q34177113-40A7A479-C52C-4861-8830-EB763EEBB15A

P356

Q34177113-BCAAA878-4A95-482F-BCA9-6AF77D17CAD6

P407

Q34177113-E5B114EF-67A8-4AFD-A693-B59C50EA3890

P433

Q34177113-2C3026FF-963D-444B-8181-327AFED1D7FA

P478

Q34177113-59D55B1B-5553-423C-ACB8-A7E13AE27FB7

P50

Q34177113-CBDDD34A-B7C7-460B-8892-5E050DD4F521

Q34177113-EAC8F6A7-E318-40A5-9C25-A73F1F463D88

P577

Q34177113-921888A4-9EDB-4E99-912D-66773FE9DE7C

P5875

Q34177113-7F03CCA2-8DD9-4CD1-AC39-1EC6D6A2DECB

P698

Q34177113-3C5A14E3-642C-4151-84C1-1F6BB8A2FC63

P921

Q34177113-C448157D-73AA-4FD6-9F94-BBA957357E0A

Q34177113-CD12039F-C991-46D5-B7FF-4AA3EB6E8DFD

P932

Q34177113-5A4F2950-F169-459F-BEF6-8EC0365C7B3F

P356

P1433

P1476

Simvastatin improves flow-medi ...... hypercholesterolemic patients

@en

P2093

Eak Kyun Shin

http://www.w3.org/2001/XMLSchema#string

Jeong Yeal Ahn

http://www.w3.org/2001/XMLSchema#string

Kwang Kon Koh

http://www.w3.org/2001/XMLSchema#string

Seung Hwan Han

http://www.w3.org/2001/XMLSchema#string

Soo Jin Kim

http://www.w3.org/2001/XMLSchema#string

Yesl Koh

http://www.w3.org/2001/XMLSchema#string

Yonghee Lee

http://www.w3.org/2001/XMLSchema#string

P2860

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage.

Inhibition by simvastatin, but not pravastatin, of glucose-induced cytosolic Ca2+ signalling and insulin secretion due to blockade of L-type Ca2+ channels in rat islet beta-cells.

Statins and newly diagnosed diabetes.

Simvastatin (40 mg/day), adiponectin levels, and insulin sensitivity in subjects with the metabolic syndrome.

Reciprocal relationships between abnormal metabolic parameters and endothelial dysfunction.

Adiponectin and cardiovascular disease: response to therapeutic interventions.

Cardiovascular actions of insulin.

P304

776-782

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC07-2199

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Michael J. Quon

P577

2008-01-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5665633

http://www.w3.org/2001/XMLSchema#string

P698

18184901

http://www.w3.org/2001/XMLSchema#string

P921

hypercholesterolemia

P932

2950311

http://www.w3.org/2001/XMLSchema#string